Stockscreener 앱 받기
109.93
2.14%
-2.40
시장 영업 전:
109.01
-0.92
-0.84%
Guardant Health Inc 주식(GH)의 최신 뉴스
Assessing Guardant Health (GH) Valuation After Analyst Upgrades And New Cancer Test Partnerships - Yahoo Finance
Guardant Health stock hits 52-week high at 112.43 USD By Investing.com - Investing.com Nigeria
Guardant Health stock jumps 7% as Evercore downgrades — what investors watch next - TechStock²
GH Virtual Meeting Scheduled by BTIG for January 12 - GuruFocus
Guardant Health (NASDAQ:GH) Stock Rating Lowered by Evercore ISI - MarketBeat
GH: Evercore ISI Group Downgrades Guardant Health While Raising Price Target | GH Stock News - GuruFocus
GH: Guggenheim Raises Price Target for Guardant Health to $115 | - GuruFocus
VIRGINIA RETIREMENT SYSTEMS ET Al Takes Position in Guardant Health, Inc. $GH - MarketBeat
Allspring Global Investments Holdings LLC Makes New $39.52 Million Investment in Guardant Health, Inc. $GH - MarketBeat
What analysts say about Guardant Health Inc stockBear Market Strategies & Explosive Growth Opportunities - earlytimes.in
Calamos Advisors LLC Takes $2.78 Million Position in Guardant Health, Inc. $GH - MarketBeat
Canaccord Names Guardant Health (GH) Top Life Science Pick, Cites Strong Growth and Low Downside - Finviz
Behavioral Patterns of GH and Institutional Flows - Stock Traders Daily
Osaic Holdings Inc. Grows Holdings in Guardant Health, Inc. $GH - MarketBeat
Guardant Health (GH) Jumps to New Record High on Earnings Blowout, Bullish Outlook - MSN
Guardant Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference - The Joplin Globe
Global Healthy Living Foundation and Guardant Health Announce Partnership to Advance Awareness of Early Colorectal Cancer Detection and Improve Access to Screening - The Joplin Globe
Why a Top Biotech Holder Sold 115,000 Mirum Shares but Still Ended Up With $185 Million on the Line - The Motley Fool
Multiple analysts lift Guardant Health, Inc. (GH) targets on screening and data growth - MSN
Capricorn Fund Managers Ltd Takes $2.26 Million Position in Guardant Health, Inc. $GH - MarketBeat
Guardant Health, Inc. (NASDAQ:GH) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Guardant Health, Inc. (NASDAQ:GH) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Genomics in Cancer Care Market to Reach USD 72.87 Billion by 2033 | - openPR.com
Multiple Analysts Lift Guardant Health, Inc. (GH) Targets on Screening and Data Growth - Yahoo Finance
Guardant Health (GH) Leads Healthcare Stocks with 226.48% YTD Ga - GuruFocus
Guardant Health is the top performing healthcare services stock YTD (GH:NASDAQ) - Seeking Alpha
7 Most Promising Gene Editing Stocks According to Analysts - Insider Monkey
Guardant Health (GH) Receives Buy Rating and $125 Price Target f - GuruFocus
Canaccord Genuity Group Issues Positive Forecast for Guardant Health (NASDAQ:GH) Stock Price - MarketBeat
(GH) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Why Guardant Health Inc. (5GH) stock could be top winnerWeekly Investment Recap & Weekly Momentum Picks - ulpravda.ru
How Guardant Health Inc. (5GH) stock reacts to stronger dollarGap Up & Weekly Sector Rotation Insights - DonanımHaber
First Week of February 2026 Options Trading For Guardant Health (GH) - Nasdaq
How strong is Guardant Health Inc. stock balance sheetJuly 2025 Highlights & Weekly Breakout Stock Alerts - DonanımHaber
Can Guardant Health Inc. (5GH) stock hold up in economic slowdown2025 Big Picture & Low Drawdown Trading Techniques - DonanımHaber
Insider Sell: Musa Tariq Sells Shares of Guardant Health Inc (GH) - GuruFocus
Guardant Health (GH) CIO reports RSU vesting and tax-share withholding - Stock Titan
Guardant Health Insider Move Sparks Fresh Buzz on Wall Street - TipRanks
[Form 4] Guardant Health, Inc. Insider Trading Activity - Stock Titan
Guardant Health (GH) CMO Craig Eagle reports RSU vesting and tax share sale - Stock Titan
Guardant Health (NASDAQ:GH) Director Sells $11,769.36 in Stock - MarketBeat
Dir Tariq Sells 116 ($11.8K) Of Guardant Health Inc [GH] - TradingView — Track All Markets
Guardant Health (GH) director exercises RSUs into 232 common shares - Stock Titan
Guardant Health (GH) director reports 116-share stock sale and holdings - Stock Titan
Will Guardant Health Inc. stock deliver better than expected guidance2025 Key Lessons & Proven Capital Preservation Tips - Улправда
Guardant Health Insider Sold Shares Worth $9,402,220, According to a Recent SEC Filing - marketscreener.com
Insider Sell: Helmy Eltoukhy Sells 90,565 Shares of Guardant Hea - GuruFocus
Analysts Are Bullish on Top Healthcare Stocks: Guardant Health (GH), Natera (NTRA) - The Globe and Mail
Insider Selling: Guardant Health (NASDAQ:GH) CEO Sells $9,402,458.30 in Stock - MarketBeat
Guardant Health (NASDAQ:GH) CTO Sells $567,122.04 in Stock - MarketBeat
Officer Freeman Acquires 808 Of Guardant Health Inc [GH] - TradingView — Track All Markets
Guardant Health Executives Sell Shares Worth Millions - TradingView — Track All Markets
Officer Chudova Sells 5,451 ($567.1K) Of Guardant Health Inc [GH] - TradingView — Track All Markets
Dir Tariq Files To Sell 116 Of Guardant Health Inc [GH] - TradingView — Track All Markets
Guardant Health (NASDAQ:GH) Price Target Raised to $120.00 - MarketBeat
GH: Mizuho Maintains Outperform Rating, Raises Price Target to $120 | GH Stock News - GuruFocus
Guardant Health, Inc. $GH Holdings Boosted by Sicart Associates LLC - MarketBeat
Oncology Biotech Challenges Rival's Cancer Testing Patent - Law360
Guardant Health price target raised to $120 from $100 at BofA - Yahoo Finance
2.56%
2.06%
자본화:
|
볼륨(24시간):